Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
502
Total Claims
$188K
Drug Cost
32
Beneficiaries
$5,890
Cost/Patient
Risk Score Breakdown 33/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
+576%
Opioid rate vs peers
42.4% vs 6.3% avg
-57%
Cost per patient vs peers
$5,890 vs $14K avg
+42%
Brand preference vs peers
20.7% vs 14.6% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Opioid prescribing rate is 576% above the average for Hematology-Oncology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
42.4%
Opioid Rate
213
Opioid Claims
$18K
Opioid Cost
27.7%
Long-Acting Rate
This provider's opioid prescribing rate of 42.4% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 104 claims · $53K
Generic: 398 claims · $136K
Patient Profile
47
Avg Age
53%
Female
3.30
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About